Epilepsy is a chronic and debilitating neurological disorder, with a worldwide prevalence of
0.5–1% and a lifetime incidence of 1–3%. An estimated 30% of epileptic patients continue to …

Ketogenic diet is an established and effective non-pharmacologic treatment for drug-
resistant epilepsy. Ketogenic diet represents the treatment of choice for GLUT-1 deficiency …

Currently available pharmacological treatment of epilepsy has limited effectiveness. In
epileptic patients, pharmacological treatment with available anticonvulsants leads to seizure …

Since 1921, dietary therapies have remained valuable options in the treatment of intractable
childhood epilepsy. The traditional ketogenic diet has been well demonstrated, including in …

Ketogenic diets: new advances for metabolism-based therapies : Current Opinion in Neurology
Ketogenic diets: new advances for metabolism-based therapies : Current Opinion in Neurology …

Ketogenic diet (KD) has been used to treat epilepsy for 100 years. It is a high-fat, low-
carbohydrate, and sufficient-protein-for-growth diet that mimics the metabolic changes …

Epilepsy is a common chronic neurological disorder characterised by recurrent unprovoked
seizures, and affects 50 million people worldwide. Approximately 30% of these do not have …

The ketogenic diet (KD) is a high-fat, low-carbohydrate, adequate-protein diet that has been
used for more than eight decades for the treatment of refractory epilepsy in children. Despite …

Recent years have witnessed an increased interest from pediatric neurologists,
neuropediatricians, epileptologists and general neurologists in the use of the ketogenic diet …

Ketogenic dietary therapies for epilepsy and beyond : Current Opinion in Clinical Nutrition &
Metabolic Care Ketogenic dietary therapies for epilepsy and beyond : Current Opinion in …